Progyny, Inc. Announces Details for Its Second Quarter 2022 Results Report

NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2022 after the close of the market on Thursday, August 4, 2022.

The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.

Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.

An audio replay of the call will be available through Thursday, August 11, 2022 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.

A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.

About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com

Media:
Selena Yang
media@progyny.com

Staff

Recent Posts

American College of Osteopathic Family Physicians Announces 2024-2025 Board of Governors

CHICAGO, IL / ACCESSWIRE / April 3, 2024 / The American College of Osteopathic Family…

3 hours ago

ACOFP Foundation Announces New Campaign, Family Medicine Forward

Campaign underscores the urgency and need to support early career osteopathic family physicians.CHICAGO, IL /…

6 hours ago

Reveal Lasers Reports First Quarter With Record-Breaking 300% Growth

LAS VEGAS, NV / ACCESSWIRE / April 3, 2024 / Reveal Lasers, a burgeoning force…

9 hours ago

Weave Enhances Integration with DrChrono by EverHealth

Deeper integration unlocks powerful Weave features to improve patient experiencesLEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a…

12 hours ago

Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that…

12 hours ago

LPW Training Services Awarded the Association for Talent Development’s Excellence in Practice for 2024

SOMERVILLE, NJ / ACCESSWIRE / April 3, 2024 / LPW Training Services, a global industry…

12 hours ago